NCT05500001 Supporting Patients by Family Education in Psychotic Illness: A Prospective Cohort Study
| NCT ID | NCT05500001 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Alberta |
| Condition | Psychotic Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 113 participants |
| Start Date | 2022-09-01 |
| Primary Completion | 2026-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 113 participants in total. It began in 2022-09-01 with a primary completion date of 2026-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Background: A lack of education, resources, and support for family carers of young adults with psychotic illnesses leaves them ill-equipped to support their loved one. Although family support groups exist, few groups offer evidence-based, skills-focused, psychoeducation taught by certified professionals and provided on a public-health level. By equipping families with skills and knowledge, public healthcare harnesses a powerful ally to maintain community stabilization. Aims: The primary study goal is to implement a psychoeducation intervention for family carers supporting young adults with psychosis to reduce family burden and foster community stabilization of service users. Methods: A longitudinal pre-post design will be used to assess the long-term effectiveness of the psychoeducation intervention for family carers supporting a young adult with psychosis on service utilization and functional indexes. Nine expert-reviewed, and family peer-informed psychoeducation modules are administered in 2-hour sessions over 9 weeks to family carers. Conclusion: Presenting the novel approach of an expert-reviewed, peer-informed psychoeducation intervention for family carers, with a focus on knowledge and skill development, the researchers contribute to literature and best practice in patient and family-centered care.
Eligibility Criteria
Inclusion Criteria: * Young adult service user is aged 17-27 at time of recruitment * Young adult service user has had an admission or discharge from an Alberta Health Services or Covenant Health psychiatric unit for psychosis in the Edmonton Zone within previous 12-months Exclusion Criteria: * Not proficient in English * Young adult service user has NOT had an admission or discharge from an Alberta Health Services or Covenant Health psychiatric unit for psychosis in the Edmonton Zone within previous 12-months
Contact & Investigator
Melanie Robles, md
PRINCIPAL INVESTIGATOR
University of Alberta
Frequently Asked Questions
Who can join the NCT05500001 clinical trial?
This trial is open to participants of all sexes, aged 17 Years or older, up to 27 Years, studying Psychotic Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05500001 currently recruiting?
Yes, NCT05500001 is actively recruiting participants. Contact the research team at maduples@ualberta.ca for enrollment information.
Where is the NCT05500001 trial being conducted?
This trial is being conducted at Edmonton, Canada, Edmonton, Canada, Edmonton, Canada, Edmonton, Canada.
Who is sponsoring the NCT05500001 clinical trial?
NCT05500001 is sponsored by University of Alberta. The principal investigator is Melanie Robles, md at University of Alberta. The trial plans to enroll 113 participants.